iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) Sees Unusually-High Trading Volume – Here’s What Happened

iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) shares saw an uptick in trading volume on Thursday . Approximately 150,079 shares traded hands during mid-day trading, a decline of 2% from the previous session’s volume of 152,840 shares.The stock last traded at $104.85 and had previously closed at $105.93.

iShares U.S. Pharmaceuticals ETF Price Performance

The firm’s 50-day moving average is $101.21 and its 200 day moving average is $93.22. The stock has a market cap of $1.69 billion, a price-to-earnings ratio of 17.75 and a beta of 0.48.

Institutional Trading of iShares U.S. Pharmaceuticals ETF

Institutional investors have recently made changes to their positions in the stock. EFG International AG acquired a new position in iShares U.S. Pharmaceuticals ETF in the fourth quarter valued at $38,000. O Shaughnessy Asset Management LLC increased its stake in iShares U.S. Pharmaceuticals ETF by 35.0% during the fourth quarter. O Shaughnessy Asset Management LLC now owns 463 shares of the company’s stock worth $39,000 after acquiring an additional 120 shares during the last quarter. Blueline Advisors LLC purchased a new position in shares of iShares U.S. Pharmaceuticals ETF in the 4th quarter worth about $41,000. Accent Capital Management LLC purchased a new position in shares of iShares U.S. Pharmaceuticals ETF in the 4th quarter worth about $42,000. Finally, National Bank of Canada FI lifted its stake in shares of iShares U.S. Pharmaceuticals ETF by 42.7% in the 3rd quarter. National Bank of Canada FI now owns 585 shares of the company’s stock valued at $42,000 after purchasing an additional 175 shares in the last quarter.

About iShares U.S. Pharmaceuticals ETF

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.